[Progress in the diagnosis and treatment of idiopathic non-cirrhotic portal hypertension]

【特发性非肝硬化性门静脉高压的诊断和治疗进展】

阅读:1

Abstract

Idiopathic non-cirrhotic portal hypertension is a rare group of clinical syndromes characterized by clinical manifestations of portal hypertension in the absence of histological manifestations of liver cirrhosis, and with the exclusion of known intrahepatic and extrahepatic causes of portal hypertension. Importantly, its etiology and pathogenesis are unclear, but it has been determined to be related to the development of intrahepatic vascular disease. It is currently believed that possible pathogenic mechanisms include immune disorders, chronic infections, drug-related poisoning or injury, microthrombosis, genetic abnormalities, etc. The most common clinical manifestations are esophagogastric varices and splenomegaly. Ascites and hepatic encephalopathy are the least common. Laboratory test demonstrates anemia, leukopenia, and thrombocytopenia due to hypersplenism, and normal or mild liver function abnormality. In addition, in the preclinical stage, despite the presence of abnormal portal vein during liver biopsy, no signs of portal hypertension can be detected in some patients. Therefore, the diagnosis is based on the diagnosis of exclusion and mandatory liver biopsy. The overall prognosis of idiopathic non-cirrhotic portal hypertension is better than that of patients with liver cirrhosis, but symptomatic treatment (controlling gastroesophageal varices bleeding and preventing thrombosis) is still the main treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。